Updates in the eighth edition of the tumor-node-metastasis staging classification for urologic cancers
GP Paner, WM Stadler, DE Hansel, R Montironi… - European urology, 2018 - Elsevier
Abstract The Tumor-Node-Metastasis (TNM) classification on cancer staging, jointly
developed by the American Joint Commission on Cancer (AJCC) and the Union for …
developed by the American Joint Commission on Cancer (AJCC) and the Union for …
Testicular cancer
Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …
age, and its incidence has risen over the past two decades in Western countries. Both …
[HTML][HTML] ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up
Abstract The European Society for Medical Oncology (ESMO) consensus conference on
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …
The present and future of serum diagnostic tests for testicular germ cell tumours
MJ Murray, RA Huddart, N Coleman - Nature Reviews Urology, 2016 - nature.com
Testicular germ cell tumours (GCTs) are the most common malignancy occurring in young
adult men and the incidence of these tumours is increasing. Current research priorities in …
adult men and the incidence of these tumours is increasing. Current research priorities in …
Developing a highly specific biomarker for germ cell malignancies: plasma miR371 expression across the germ cell malignancy spectrum
L Nappi, M Thi, A Lum, D Huntsman, BJ Eigl… - Journal of clinical …, 2019 - ascopubs.org
PURPOSE Our objective was to evaluate operating characteristics, particularly specificity
and positive predictive value (PPV), by mapping plasma miR371 expression to actual …
and positive predictive value (PPV), by mapping plasma miR371 expression to actual …
[图书][B] TNM supplement: a commentary on uniform use
C Wittekind, JD Brierley, A Lee, E Van Eycken - 2019 - books.google.com
The Union for International Cancer Controls (UICC) TNM classification system is the most
widely used cancer classification and staging system in the world. It is used to describe the …
widely used cancer classification and staging system in the world. It is used to describe the …
[HTML][HTML] Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy: a …
T Tandstad, O Ståhl, O Dahl, HS Haugnes… - Annals of …, 2016 - Elsevier
Background The purpose of the protocol was to reduce the treatment burden in clinical stage
I (CSI) seminoma by offering risk-adapted treatment. The protocol aimed to prospectively …
I (CSI) seminoma by offering risk-adapted treatment. The protocol aimed to prospectively …
Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic …
JL Boormans, JM de Castro, L Marconi, Y Yuan… - European urology, 2018 - Elsevier
Context Patients with clinical stage I (CS I) seminoma testis with large primary tumours
and/or rete testis invasion (RTI) might have an increased risk of relapse. In recent years …
and/or rete testis invasion (RTI) might have an increased risk of relapse. In recent years …
Utility of serum miR-371a-3p in predicting relapse on surveillance in patients with clinical stage I testicular germ cell cancer
J Lobo, R Leao, AJM Gillis, A van den Berg… - European Urology …, 2021 - Elsevier
Background Optimal management of clinical stage I (CSI) testicular cancer is controversial
due to lack of robust prognostic factors; miRNA-371a-3p holds promise as a biomarker …
due to lack of robust prognostic factors; miRNA-371a-3p holds promise as a biomarker …
Advances in diagnosis and treatment of testicular cancer
M Chovanec, L Cheng - bmj, 2022 - bmj.com
Testicular cancer is a curable cancer. The success of physicians in curing the disease is
underpinned by multidisciplinary advances. Cisplatin-based combination chemotherapy and …
underpinned by multidisciplinary advances. Cisplatin-based combination chemotherapy and …